References
Brooks G, Walsh R, Downey JM. Phosphorylation of 80 K/MARCKS, a specific substrate of protein kinase C, occurs after 5' ischemia but only in preconditioned hearts (abstr). Circulation 1993;(Suppl. II):1-101.
Armstrong SC, Ganote CE. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on metabolically inhibited and ischaemic isolated myocytes. J Mol Cell Cardiol 1992;24:869-884.
Armstrong SC, Kao R, Gao W, Shivel' LO, Downey JM, Honkanen RE, Ganote CE. Comparison of in vitro preconditioning responses of isolated pig and rabbit cardiomyocytes: Effects of protein phosphatase inhibitor, fostriecin. J Mol Cell Cardiol 1997;29:3009-3024.
Armstrong SC, Gao W, Lane JR, Ganote CE. Protein phosphatase inhibitors calyculin A and fostriecin protect rabbit cardiomyocytes in late ischemia. J Mol Cell Cardiol 1998;30:61-73.
Cumming DVE, Heads RJ, Coffin RS, Yellon DM, Latchman DS. Pharmacological preconditioning of primary rat cardiac myocytes by FK506. Basic Res Cardiol 1996;91:367-373.
Massoudy P, Zahler S, Kupatt C, Reder E, Becker BF, Gerlach E. Cardioprotection by cyclosporine A in experimental ischemia and reperfusion-evidence for a nitric oxide-dependent mechanism mediated by endothelin. J Mol Cell Cardiol 1997;29:535-544.
Schaper W. Experimental infarcts and the microcirculation. In: Hearse DJ, Yellon DM, eds. Therapeutic Approaches to Myocardial Infarct Size Limitation. New York: Raven Press, 1984:79-90.
Cairns J, Qin S, Philp R, Tan YH, Guy GR. Dephosphorylation of the small heat shock protein Hsp27 in vivo by protein phosphatase 2A. J Biol Chem 1994;269:9176-9183.
Kato K, Hasegawa K, Goto S, Inaguma Y. Dissociation as a result of phosphorylation of an aggregated form of the small stress protein, Hsp27. J Biol Chem 1994;269:11274-11278.
Zimmermann N, Gams E, Neumann J, Boknik P, Scholz H. Effects of cyclosporine on protein phosphorylation in the heart. Transplant Proc 1994;26:2875-2876.
Ganote C, Armstrong S. Ischaemia and the myocyte cytoskeleton: Review and speculation. Cardiovasc Res 1993; 27:1387-1403.
Duchen MR, McGuinness O, Brown LA, Crompton M. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res 1993;27:1790-1794.
Mijares A, Malecot CO, Peineau N, Argibay JA. In vivo and in vitro inhibition of the L-type calcium current in isolated guinea-pig cardiomyocytes by the immunosuppressive agent cyclosporin A. J Mol Cell Cardiol 1997;29:2067-2076.
Weinbrenner C, Downey JM, Cohen MV. Cyclosporin a preconditions rabbit heart when administered before as well as after onset of ischemia. Circulation 1997;96(Suppl.):I252-I253.
Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136-142.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cai, Q., Baxter, G.F. & Yellon, D.M. Reduction of Infarct Size in Isolated Rat Heart by CsA and FK506: Possible Role of Phosphatase Inhibition. Cardiovasc Drugs Ther 12, 499–501 (1998). https://doi.org/10.1023/A:1007745814463
Issue Date:
DOI: https://doi.org/10.1023/A:1007745814463